Director, Patient Identification Programs

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical thoughtful use of AI to improve clarity, speed, and quality of work. What You'll Do Maverick wanted! We’re seeking a Director of Patient Identification Programs responsible for designing, operationalizing, leading, and scaling enterprise-wide patient identification strategies that enable timely diagnosis, and access to approved therapies. This role sits at the intersection of commercial strategy, data science, medical affairs, clinical development, and external partnerships, and plays a critical role in accelerating patient journeys towards diagnosis and treatment. The Director will design, build, and manage a portfolio of innovative patient identification initiatives, leveraging real-world data, diagnostic pathways, digital tools, and healthcare ecosystem partnerships to identify, educate, and connect eligible patients to appropriate genetic testing, clinical programs, or treatments. Responsibilities Strategy Leadership Develop and execute a comprehensive patient identification strategy aligned with commercial launch and pipeline priorities, disease areas, and corporate objectives. Serve as the enterprise subject-matter expert on patient identification, diagnostic pathways, and unmet diagnostic needs. Lead and mentor cross-functional contributors to patient identification programs. Program Design Execution Design and operationalize patient identification programs focused on (pre-)commercial stage and – to a lesser extent – clinical stage programs. Leverage initiatives such as diagnostic algorithms, EHR-based identification, biomarker screening, genetic testing programs, and referral pathways. Ensure programs are scalable, compliant, and adaptable across geographies and indications. Cross-Functional Collaboration Partner closely with Commercial, Medical Affairs, Data Science, Market Access, Regulatory, Legal/Compliance, Clinical Development teams Align patient identification efforts with launch readiness plans Provide strategic input into evidence generation and disease education initiatives Data Analytics Leverage real-world data (claims, EHR, genomics, registries) to identify patient populations and optimize identification approaches Define success metrics, dashboards, and KPIs to measure program impact and inform continuous improvement Translate data insights into actionable recommendations for internal stakeholders External Partnerships Build and manage relationships with diagnostic companies, health systems, laboratories, advocacy groups, digital health vendors, and data partners Evaluate and onboard innovative technologies and vendors to enhance patient identification capabilities Represent the company externally as a thought leader in patient identification and rare disease diagnosis Governance Compliance Ensure all programs adhere to applicable regulatory, privacy, and compliance requirements (e.g., HIPAA, GDPR, promotional regulations) Partner with Legal and Compliance to design ethical, patient-centric programs that prioritize trust and transpare ... (truncated, view full listing at source)